BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24121902)

  • 1. Expression of hormonal receptors in osteosarcomas of the jaw bones: clinico-pathological analysis of 21 cases.
    Domínguez-Malagón HR; González-Conde E; Cano-Valdez AM; Luna-Ortiz K; Mosqueda-Taylor A
    Med Oral Patol Oral Cir Bucal; 2014 Jan; 19(1):e44-8. PubMed ID: 24121902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ezrin and metastatic tumor antigen in osteosarcomas of the jaw.
    Park HR; Cabrini RL; Araujo ES; Paparella ML; Brandizzi D; Park YK
    Tumori; 2009; 95(1):81-6. PubMed ID: 19366061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative, apoptotic and angiogenic potentials in jaws and long bones osteosarcomas: a comparative immunohistochemical study.
    Jawad SN; Abdullah BH
    J Oral Pathol Med; 2010 Oct; 39(9):681-6. PubMed ID: 20701666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors.
    Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
    J Urol; 2004 Feb; 171(2 Pt 1):611-4. PubMed ID: 14713771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade osteosarcoma is predominant in gnathic osteosarcomas: A report of seven cases of osteosarcoma of the jaw.
    Sasaki A; Miyashita H; Kawaida M; Kameyama K
    Clin Exp Dent Res; 2021 Dec; 7(6):1175-1182. PubMed ID: 34008925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenic sarcoma of the jaw: a 10-year experience.
    Fernandes R; Nikitakis NG; Pazoki A; Ord RA
    J Oral Maxillofac Surg; 2007 Jul; 65(7):1286-91. PubMed ID: 17577490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcomas of jaw: experience of a single centre.
    Argon A; Doğanavşargıl B; Ünal Yıldırım F; Sezak M; Midilli R; Öztop F
    J Plast Surg Hand Surg; 2015 Feb; 49(1):13-8. PubMed ID: 24780088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Jaw osteosarcomas].
    Steve M; Ernenwein D; Chaine A; Bertolus C; Goudot P; Ruhin-Poncet B
    Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):286-92. PubMed ID: 21943494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas.
    Junior AT; de Abreu Alves F; Pinto CA; Carvalho AL; Kowalski LP; Lopes MA
    Oral Oncol; 2003 Jul; 39(5):521-30. PubMed ID: 12747978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations.
    Kulungowski AM; Hassanein AH; Nosé V; Fishman SJ; Mulliken JB; Upton J; Zurakowski D; DiVasta AD; Greene AK
    Plast Reconstr Surg; 2012 Jun; 129(6):919e-924e. PubMed ID: 22634690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of sexual hormon receptors in prostatic cancer tissues].
    Ding T; Che WJ; Chen TJ
    Zhonghua Nan Ke Xue; 2006 Jan; 12(1):50-2, 56. PubMed ID: 16483160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor expression in gastrointestinal stromal tumor.
    Lopes LF; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):146-50. PubMed ID: 19077908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
    Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
    J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteosarcoma of the craniofacial bones. A clinico-pathological study.
    Vege DS; Borges AM; Aggrawal K; Balasubramaniam G; Parikh DM; Bhaser B
    J Craniomaxillofac Surg; 1991 Feb; 19(2):90-3. PubMed ID: 2037699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into Expression of Hormonal Receptors by Meningiomas.
    Portet S; Banor T; Bousquet J; Simonneau A; Flores M; Ingrand P; Milin S; Karayan-Tapon L; Bataille B
    World Neurosurg; 2020 Aug; 140():e87-e96. PubMed ID: 32371078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteosarcoma of jaw: the experience of Chang Gung Memorial Hospital.
    Chen JS; Liaw CC; Wang HM; Tsai MH; Hao SP; Hsueh S
    Changgeng Yi Xue Za Zhi; 1995 Sep; 18(3):260-5. PubMed ID: 8521337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcome of weak estrogen/progesterone receptor expression in HER2 negative breast cancer is similar to triple negative breast cancer.
    Liao GS; Dai MS; Hsu HM; Chu CH; Hong ZJ; Fu CY; Chou YC; Huang TC; Yu JC
    Eur J Surg Oncol; 2017 Oct; 43(10):1855-1861. PubMed ID: 28756019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma of the jaw: an analysis of a series of 74 cases.
    Paparella ML; Olvi LG; Brandizzi D; Keszler A; Santini-Araujo E; Cabrini RL
    Histopathology; 2013 Oct; 63(4):551-7. PubMed ID: 23889216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.